LSE - AIM:HCM

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 8th and 9th, 2023

Retrieved on: 
Wednesday, November 1, 2023
Deutsche Bank, ASX, HKEX, Sale, EMH, QBE, Bank, OTCQX, QBE Insurance, ADR, OTC, Conference, Receipt, UK, Metal, American depositary receipt, Cryptocurrency, Security (finance)

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Wednesday, November 8 and Thursday, November 9, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.

Key Points: 
  • NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Wednesday, November 8 and Thursday, November 9, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.
  • The conference is targeted to all categories of investors and analysts interested in non-US companies.
  • There is no fee for participants to log in, attend live presentations and/or ask questions.
  • Deutsche Bank is sponsoring the Deutsche Bank Depositary Receipt Investor Conference solely for informational purposes.

Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology

Retrieved on: 
Friday, December 16, 2022

"With the addition of ACT’s technologies, capabilities and team, Prenetics will be well-positioned to accelerate the utilization of genetic information throughout a cancer patient's journey.

Key Points: 
  • "With the addition of ACT’s technologies, capabilities and team, Prenetics will be well-positioned to accelerate the utilization of genetic information throughout a cancer patient's journey.
  • In connection with the acquisition, Prof. Tony Mok will be appointed to Prenetics Scientific Advisory Board, effective January 1, 2023.
  • "ACT has achieved breakthrough success since its founding in 2014, and had joined forces with Sanomics since 2021 in pioneering and promoting precision medicine cancer treatment management.
  • I am incredibly proud and excited about the future impact of Prenetics and ACT on patient care."